The Schwab Fundamental U.S. Large Company Index ETF (FNDX) provides investors with a diversified portfolio weighted by fundamental factors, emphasizing value stocks and steady dividend growth. Launched in 2013, FNDX maintains lower sector and company concentration risks compared to the Russell 1000, with no sector exceeding 16% and the largest issuer at 4.5%. While FNDX has outperformed the Russell 1000 over the past 12 months, it has generally lagged behind the benchmark since inception and trails a close competitor, IUS, in recent returns. This ETF is favored by investors seeking a fundamentally weighted approach with risk diversification and income potential.
The global infant heart monitor market, valued at $2.83 billion in 2025, is projected to grow to $7.93 billion by 2035 at a CAGR of 10.85%. Growth is fueled by advances in wearable and wireless monitoring technologies, increased adoption of home care...
The European Commission has approved TEPKINLY (epcoritamab) combined with lenalidomide and rituximab for treating relapsed or refractory follicular lymphoma in adults. This marks the first bispecific antibody-based therapy authorized in Europe for se...
Halper Sadeh LLC is investigating whether shareholders of Arcosa, Bio-Techne, Iridium Communications, and LCI Industries are receiving fair deals in their companies' recent sales. The law firm suspects insiders may gain financial benefits not availab...
Law Offices of Howard G. Smith has announced upcoming deadlines for investors to file lead plaintiff motions in class action lawsuits against BitGo Holdings, Via Transportation, Zillow Group, and ADMA Biologics. These lawsuits allege that the compani...
The global waterborne epoxy resins market, valued at $4.98 billion in 2024, is projected to grow at a CAGR of 6.03% to $8.51 billion by 2034. This growth is fueled by strict international regulations targeting volatile organic compound emissions and ...
